NCT06781892 Strategies for Defibrillation During Out-of-Hospital Cardiac Arrest
| NCT ID | NCT06781892 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lars Wiuff Andersen |
| Condition | Cardiac Arrest (CA) |
| Study Type | INTERVENTIONAL |
| Enrollment | 909 participants |
| Start Date | 2025-03-15 |
| Primary Completion | 2028-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 909 participants in total. It began in 2025-03-15 with a primary completion date of 2028-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The "Strategies for Defibrillation during Out-of-Hospital Cardiac Arrest" (STRAT-DEFI) trial is an investigator-initiated, individually randomized, 3-group clinical trial comparing standard anterior-lateral pad positioning with anterior-posterior positioning and double sequential defibrillation during adult out-of-hospital cardiac arrest.
Eligibility Criteria
Inclusion Criteria: 1. Out-of-hospital cardiac arrest 2. Age ≥ 18 years 3. ≥ 1 manual defibrillation attempt by emergency medical services 4. Shockable rhythm as the last known rhythm 5. Two manual defibrillators present on-site Exclusion Criteria: 1. Blunt trauma, penetrating trauma, or burn injury suspected to be the cause of the cardiac arrest 2. Prior enrollment in the trial 3. Posterior pad placement not deemed possible by on-site clinician
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06781892 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Arrest (CA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06781892 currently recruiting?
Yes, NCT06781892 is actively recruiting participants. Contact the research team at lwandersen@clin.au.dk for enrollment information.
Where is the NCT06781892 trial being conducted?
This trial is being conducted at Aalborg, Denmark, Aarhus N, Denmark, Aarhus N, Denmark, Ballerup Municipality, Denmark and 2 additional locations.
Who is sponsoring the NCT06781892 clinical trial?
NCT06781892 is sponsored by Lars Wiuff Andersen. The trial plans to enroll 909 participants.